Celltrion holdings Nasdaq
Scope
Date
~
-
Mergers & Acquisitions
Qoo10 to buy another Korean rival for unit’s Nasdaq listing
Southeast Asia-based e-commerce platform Qoo10 Pte. Ltd. is poised to take over a smaller South Korean rival through a stock swap deal, in a bid to ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Genuv sign agreement for antibody joint R&D
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday a joint research and development agreement with Genuv, Inc., a domestic drug...
Mar 14, 2023 (Gmt+09:00)
-
Corporate governance
POSCO Engineering & Construction renames itself POSCO E&C
POSCO Engineering & Construction, the builder affiliate of South Korea's POSCO Group, has changed its name to "POSCO E&C" to mark the first ...
Mar 09, 2023 (Gmt+09:00)
-
Shareholder activism
KT&G’s hidden saviors in activist fight: In-house funds
KT&G Corp., the world’s fifth-largest tobacco maker, will likely get support from in-house shareholders in a battle against activist funds...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion ex-Chairman Seo set to return to management; group stocks rally
South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Central bank
BOK holds rates as it lowers growth, inflation forecasts
South Korea’s central bank held its policy interest rate unchanged on Thursday as it slashed forecasts for economic growth and inflation altho...
Feb 23, 2023 (Gmt+09:00)
-
Upcoming IPOs
Car-sharing platform Humax Mobility begins IPO process
Humax Mobility, a South Korean car-sharing and parking platform operator, is aiming to become the second mobility service firm to go public in the c...
Feb 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Korean stock market
Samsung C&T to cancel $2.3 bn worth of treasury shares, stocks up
Samsung C&T Corp.’s share price zoomed on Thursday on news that the company will cancel its entire treasury stock holdings worth about 2.9...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Truxima shows safety, efficacy in post-marketing study
South Korean biopharmaceutical company Celltrion Inc. reported on Wednesday that its biosimilar drug Truxima (rituximab), a generic version of Roche...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm holds sales meeting for marketing Cenobamate in US
On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...
Feb 16, 2023 (Gmt+09:00)
-
Supply chain
S.Korea, Mongolia discuss stabilization of mineral supply chains
The Korea Chamber of Commerce and Industry and Mongolian National Chamber of Commerce and Industry in Seoul on Tuesday held a business forum o...
Feb 15, 2023 (Gmt+09:00)
-
Shareholder activism
Korea’s Hyundai Dept. Store drops holding company plan
South Korea’s major retailer Hyundai Department Store Group Co. gave up a plan to split off its core high-end shopping mall affiliate and conv...
Feb 10, 2023 (Gmt+09:00)
-
Banking & Finance
Shinhan Financial returns to top in Korea with record NP in 2022
Shinhan Financial Group Co. reported a record-high net profit of 4.6 trillion won ($3.6 billion) last year, snatching back the crown of South Korea&...
Feb 09, 2023 (Gmt+09:00)
-
Insurance
Kyobo Life Insurance speeds up creation of holding company
South Korea’s Kyobo Life Insurance Co. is set to establish a holding company by the second half of 2024. The major insurer seeks to raise its ...
Feb 08, 2023 (Gmt+09:00)
-
Batteries
Citibank Korea provides $412 mn to POSCO for Argentine business
Citibank Korea signed on Jan. 25 a financial contract with POSCO Argentina, a subsidiary of South Korea's steel and secondary battery raw material g...
Feb 06, 2023 (Gmt+09:00)
-
Banking & Finance
KB Financial Group holds investment conference via metaverse
South Korea's KB Financial Group on Tuesday presented its investment philosophy to individual and institutional customers in the metaverse, a three-...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
DongKoo Bio signs MOU to move into SE Asian healthcare market
DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, th...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion increases its stake in British ADC developer Iksuda
Celltrion Inc. has secured an additional stake in the UK's antibody-drug conjugate (ADC) developer Iksuda Therapeutics.According to Celltrion on Wed...
Jan 25, 2023 (Gmt+09:00)
-
Earnings
POSCO turns to red in Q4 on typhoon, weak steel demand
POSCO Holdings Inc., the holding company of South Korea’s top steelmaker, turned to the red in the fourth quarter of 2022 hit by a typhoon and...
Jan 20, 2023 (Gmt+09:00)
-
Leadership & Management
Samsung hires ex-Yogiyo CEO to lead online sales as rivals axe jobs
Samsung Electronics Co. has hired Kang Shin-bong, former chief executive of Yogiyo, South Korea’s second-largest food delivery platform, to le...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Korean startups
Major startup event Slush to hold spin-off meeting in Korea
Slush, one of the world’s largest startup events, is set to hold a spin-off meeting in South Korea this year.Slush is a startup and tech event...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare lands biosimilar deal in Brazil for 2nd straight year
South Korea's Celltrion Healthcare Co. on Tuesday said that for the second straight year, it landed an order for infliximab, an antibody used to tre...
Jan 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires approval to sell Vegzelma in Canada
South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...
Jan 05, 2023 (Gmt+09:00)
-
Corporate investment
S.Korea Inc. ramps up cash reserves amid economic woes
South Korean companies are rushing to raise cash from the beginning of the new year amid growing concerns over a global economic downturn and market...
Jan 03, 2023 (Gmt+09:00)
-
Electric vehicles
SK Networks completes acquisition of local EV charging platform operator
SK Networks Co., a South Korean general trading firm, said on Jan. 3 it has completed the acquisition of SS Charger Co., a leading electric car char...
Jan 03, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand